Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
MedCap AB, established in 2001 and headquartered in Stockholm, Sweden, is a private equity firm specializing in the acquisition and development of small to medium-sized companies within the life sciences sector. The firm focuses on three primary business areas: MedTech, Assistive Tech, and Specialty Pharma. MedCap's portfolio includes subsidiaries such as Abilia, which operates in assistive technology; Cardiolex, specializing in ECG solutions; and Unimedic, involved in specialty pharmaceuticals. The company primarily targets investments in Northern Europe, aiming to support businesses with international growth potential. MedCap typically acquires majority stakes, providing capital, expertise, and networks to foster long-term development.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
MedCap ABEli Lilly
Last price
kr 552.50$1,417.54
Currency
SEK
USD
kr 8.3B$1.3T
30.1846.01
kr 18.30$30.81
0.470.45
0$6.69
00.49%
Sector
HealthHealth
Employees
66350,000
Ticker
Skr MCAP$LLY
Primary listing
XSTONYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in SkrMCAP or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.